FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2029567666> ?p ?o ?g. }

• W2029567666 endingPage "133" @default.
• W2029567666 startingPage "128" @default.
• W2029567666 abstract "Interferon-based regimens (alone or with ribavairin) are standard therapies for chronic hepatitis C. The aim of this study was to compare a 24-week regimen of interferon alpha-2b + ribavirin (IFN + RIBA) to interferon alpha-2b + amantadine (IFN + AMANT) in non-responders to previous interferon monotherapy.In a multi-center, double-blind clinical trial, 118 patients (non-responders to previous interferon monotherapy) were equally randomized into the two arms: interferon alpha-2b (3 MU thrice weekly) and ribavirin (800 mg daily) vs. interferon alpha-2b (3 MU thrice weekly) and amantadine (200 mg daily).After 24 weeks of therapy, HCV RNA became undetectable in 34.8% (95% CI: 23.7-49.2) of IFN + RIBA and 19.6% (95% CI: 10.6-34.7) of IFN + AMANT (P = 0.10). This response was sustained in 3.9% (95% CI: 1.0-14.9) of IFN + RIBA and 0% of IFN + AMANT (P = 0.16). Ten patients from IFN + AMANT (17%) and 12 patients (20%) from IFN + RIBA were discontinued before completion of therapy. Of these, 7% in IFN + AMANT and 12% in IFN + RIBA were discontinued due to adverse effects.Re-treatment of interferon non-responders with a 24-week course of IFN + AMANT was not associated with any sustained viral eradication. Although IFN + RIBA in this group was associated with a reasonable end of treatment response, relapses were common and sustained responses were low." @default.
• W2029567666 created "2016-06-24" @default.
• W2029567666 creator A5000365846 @default.
• W2029567666 creator A5006909465 @default.
• W2029567666 creator A5013347729 @default.
• W2029567666 creator A5046665689 @default.
• W2029567666 creator A5049019266 @default.
• W2029567666 creator A5054702427 @default.
• W2029567666 creator A5063932843 @default.
• W2029567666 creator A5066928250 @default.
• W2029567666 creator A5078664858 @default.
• W2029567666 creator A5080386622 @default.
• W2029567666 creator A5089186890 @default.
• W2029567666 date "2001-01-01" @default.
• W2029567666 modified "2023-10-16" @default.
• W2029567666 title "A randomized, double-blind controlled trial of interferon alpha-2b and ribavirin vs. interferon alpha-2b and amantadine for treatment of chronic hepatitis C non-responder to interferon monotherapy" @default.
• W2029567666 cites W1979931682 @default.
• W2029567666 cites W1993974155 @default.
• W2029567666 cites W2005863439 @default.
• W2029567666 cites W2015516436 @default.
• W2029567666 cites W2021819865 @default.
• W2029567666 cites W2028145691 @default.
• W2029567666 cites W2037555620 @default.
• W2029567666 cites W2058361955 @default.
• W2029567666 cites W2062802394 @default.
• W2029567666 cites W2079002457 @default.
• W2029567666 cites W2085684927 @default.
• W2029567666 cites W2133580842 @default.
• W2029567666 cites W2313828343 @default.
• W2029567666 cites W2314619766 @default.
• W2029567666 cites W2317554121 @default.
• W2029567666 cites W2318639814 @default.
• W2029567666 cites W2333688702 @default.
• W2029567666 cites W2336799715 @default.
• W2029567666 doi "https://doi.org/10.1016/s0168-8278(00)00003-9" @default.
• W2029567666 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11211889" @default.
• W2029567666 hasPublicationYear "2001" @default.
• W2029567666 type Work @default.
• W2029567666 sameAs 2029567666 @default.
• W2029567666 citedByCount "47" @default.
• W2029567666 countsByYear W20295676662012 @default.
• W2029567666 countsByYear W20295676662014 @default.
• W2029567666 countsByYear W20295676662015 @default.
• W2029567666 crossrefType "journal-article" @default.
• W2029567666 hasAuthorship W2029567666A5000365846 @default.
• W2029567666 hasAuthorship W2029567666A5006909465 @default.
• W2029567666 hasAuthorship W2029567666A5013347729 @default.
• W2029567666 hasAuthorship W2029567666A5046665689 @default.
• W2029567666 hasAuthorship W2029567666A5049019266 @default.
• W2029567666 hasAuthorship W2029567666A5054702427 @default.
• W2029567666 hasAuthorship W2029567666A5063932843 @default.
• W2029567666 hasAuthorship W2029567666A5066928250 @default.
• W2029567666 hasAuthorship W2029567666A5078664858 @default.
• W2029567666 hasAuthorship W2029567666A5080386622 @default.
• W2029567666 hasAuthorship W2029567666A5089186890 @default.
• W2029567666 hasConcept C126322002 @default.
• W2029567666 hasConcept C168563851 @default.
• W2029567666 hasConcept C203014093 @default.
• W2029567666 hasConcept C2522874641 @default.
• W2029567666 hasConcept C2776178377 @default.
• W2029567666 hasConcept C2776455275 @default.
• W2029567666 hasConcept C2776999253 @default.
• W2029567666 hasConcept C2777374534 @default.
• W2029567666 hasConcept C2780040827 @default.
• W2029567666 hasConcept C2781228144 @default.
• W2029567666 hasConcept C2781413609 @default.
• W2029567666 hasConcept C2909179924 @default.
• W2029567666 hasConcept C3020491458 @default.
• W2029567666 hasConcept C71924100 @default.
• W2029567666 hasConcept C90924648 @default.
• W2029567666 hasConcept C98274493 @default.
• W2029567666 hasConceptScore W2029567666C126322002 @default.
• W2029567666 hasConceptScore W2029567666C168563851 @default.
• W2029567666 hasConceptScore W2029567666C203014093 @default.
• W2029567666 hasConceptScore W2029567666C2522874641 @default.
• W2029567666 hasConceptScore W2029567666C2776178377 @default.
• W2029567666 hasConceptScore W2029567666C2776455275 @default.
• W2029567666 hasConceptScore W2029567666C2776999253 @default.
• W2029567666 hasConceptScore W2029567666C2777374534 @default.
• W2029567666 hasConceptScore W2029567666C2780040827 @default.
• W2029567666 hasConceptScore W2029567666C2781228144 @default.
• W2029567666 hasConceptScore W2029567666C2781413609 @default.
• W2029567666 hasConceptScore W2029567666C2909179924 @default.
• W2029567666 hasConceptScore W2029567666C3020491458 @default.
• W2029567666 hasConceptScore W2029567666C71924100 @default.
• W2029567666 hasConceptScore W2029567666C90924648 @default.
• W2029567666 hasConceptScore W2029567666C98274493 @default.
• W2029567666 hasIssue "1" @default.
• W2029567666 hasLocation W20295676661 @default.
• W2029567666 hasLocation W20295676662 @default.
• W2029567666 hasOpenAccess W2029567666 @default.
• W2029567666 hasPrimaryLocation W20295676661 @default.
• W2029567666 hasRelatedWork W1595172314 @default.
• W2029567666 hasRelatedWork W1986651510 @default.
• W2029567666 hasRelatedWork W1992295262 @default.
• W2029567666 hasRelatedWork W2003328227 @default.
• W2029567666 hasRelatedWork W2075891457 @default.
• W2029567666 hasRelatedWork W2120501783 @default.

• next